Published :
Tables : 19
Figures : 31
Category : Healthcare
No. of Pages : 215
Report Code : HC-1016
Infectious Disease Testing Market Introduction: Global infectious disease testing market to achieve beyond $24 billion mark by 2027 end, registering a CAGR of 5.8% during the forecast period of 2020-2027. Infectious disease is caused by bacteria, virus and others and has a huge impact on healthcare systems of the countries. Infectious disease testing is the process of identification of causative organism for the primary diagnosis of diseases.Infectious diseases testing samples include blood, urine and other bodily fluids. Diagnosis is primary requisite for disease management, so infectious disease testing plays a very important role in primary healthcare settings. Increasing epidemics of infectious diseases require continuous testing and led robust growth of the market. Infectious diseases have a huge impact on healthcare systems due to high disease burden. Because of this, government bodies made it mandatory to run infectious disease testing across different domains. It created potential opportunities for infectious disease testing manufacturers and boosted the growth of the market. Further, changing regulatory policies to mandate the infectious disease testing for the general population fuelled the growth of the market. Along with these, technology has integrated the existing manual operations and led to the development of a fully automated process. Others factors like increasing awareness among the general population regarding the drastic effects of infectious diseases have boosted the robust growth of the infectious disease testing market. Developing economies made it mandatory for testing the general population regarding the infectious disease epidemics has boosted the growth of North America and Europe. North America infectious disease testing market accounts major share in the global market due to high penetration among the end users. It is followed by Europe and it witnessed a significant share due to stringent government policies. Asia Pacific and Latin America Infectious Disease Testing market is the most lucrative space for manufacturers due to high prevalence of infectious diseases. Rest of the world witnessed significant growth during the forecast period due to increasing awareness. Infectious disease testing manufacturers include Abbott Laboratories, Becton, Dickinson And Company, Biomérieux Sa, Bio-rad Laboratories, Danaher Corporation, Diasorin, Luminex, Meridian Bioscience, Quidel, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific. Impact of COVID-19 on Infectious Disease Testing Market: Many diagnostic test manufacturers have initiated to develop and commercialize devices that facilitate testing procedures outside lab settings. These kits are capable of detecting COVID-19 proteins from the respiratory samples such as throat swab and sputum or through serum or blood. But WHO has recommended to use these point-of-care tests specifically in research settings. The rapid diagnostic testing is capable of detecting the presence of antigens of the novel coronavirus from a respiratory tract sample. Such advancements shall contribute in the market growth. Infectious Disease Testing Market Segmentation By Product & Service Assays, Kits, & Reagents Instruments Services & Software By Technology Immunodiagnostics Clinical Microbiology Polymerase Chain Reaction (Pcr) Isothermal Nucleic Acid Amplification Technology (Inaat) Dna Sequencing & Next-generation Sequencing (Ngs) Dna Microarray Other Technologies By Disease Type Hepatitis Human Immunodeficiency Virus (Hiv) Chlamydia Trachomatis Genital Infection And Gonorrhea (Ct/Ng) Hospital-acquired Infections (Hais) Human Papillomavirus (Hpv) Tuberculosis (Tb) Influenza Others By End User Hospital/Clinical Laboratories Reference Laboratories Physician Offices Academic/Research Institutes Others By Region Europe North America APAC Latin America Rest of World Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Takeaways Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global infectious disease testing market on the basis of product & service, technology, disease type, end user and region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and an overall market To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization services offered are free of charge with purchase of any license of the report. You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Global infectious disease testing market to achieve beyond $24 billion mark by 2027 end, registering a CAGR of 5.8% during the forecast period of 2020-2027.
Infectious disease is caused by bacteria, virus and others and has a huge impact on healthcare systems of the countries. Infectious disease testing is the process of identification of causative organism for the primary diagnosis of diseases.Infectious diseases testing samples include blood, urine and other bodily fluids. Diagnosis is primary requisite for disease management, so infectious disease testing plays a very important role in primary healthcare settings.
Increasing epidemics of infectious diseases require continuous testing and led robust growth of the market. Infectious diseases have a huge impact on healthcare systems due to high disease burden. Because of this, government bodies made it mandatory to run infectious disease testing across different domains. It created potential opportunities for infectious disease testing manufacturers and boosted the growth of the market. Further, changing regulatory policies to mandate the infectious disease testing for the general population fuelled the growth of the market. Along with these, technology has integrated the existing manual operations and led to the development of a fully automated process. Others factors like increasing awareness among the general population regarding the drastic effects of infectious diseases have boosted the robust growth of the infectious disease testing market.
Developing economies made it mandatory for testing the general population regarding the infectious disease epidemics has boosted the growth of North America and Europe. North America infectious disease testing market accounts major share in the global market due to high penetration among the end users. It is followed by Europe and it witnessed a significant share due to stringent government policies. Asia Pacific and Latin America Infectious Disease Testing market is the most lucrative space for manufacturers due to high prevalence of infectious diseases. Rest of the world witnessed significant growth during the forecast period due to increasing awareness.
Infectious disease testing manufacturers include Abbott Laboratories, Becton, Dickinson And Company, Biomérieux Sa, Bio-rad Laboratories, Danaher Corporation, Diasorin, Luminex, Meridian Bioscience, Quidel, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific.
Impact of COVID-19 on Infectious Disease Testing Market:
Many diagnostic test manufacturers have initiated to develop and commercialize devices that facilitate testing procedures outside lab settings. These kits are capable of detecting COVID-19 proteins from the respiratory samples such as throat swab and sputum or through serum or blood. But WHO has recommended to use these point-of-care tests specifically in research settings. The rapid diagnostic testing is capable of detecting the presence of antigens of the novel coronavirus from a respiratory tract sample. Such advancements shall contribute in the market growth.
Infectious Disease Testing Market Segmentation
By Product & Service
By Technology
By Disease Type
By End User
By Region
Competitive Landscape:
FutureWise Takeaways
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Infectious Disease Testing Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Infectious Disease Testing Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Infectious Disease Testing Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Infectious Disease Testing Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Infectious Disease Testing Market, By Product & Service Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Assays, Kits, & Reagents 7.2. Instruments 7.3. Services & Software 8. Global Infectious Disease Testing Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Immunodiagnostics 8.2. Clinical Microbiology 8.3. Polymerase Chain Reaction (Pcr) 8.4. Isothermal Nucleic Acid Amplification Technology (Inaat) 8.5. Dna Sequencing & Next-generation Sequencing (Ngs) 8.6. Dna Microarray 8.7. Other Technologies 9. Global Infectious Disease Testing Market, By Disease Type Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Hepatitis 9.2. Human Immunodeficiency Virus (Hiv) 9.3. Chlamydia Trachomatis Genital Infection And Gonorrhea (Ct/Ng) 9.4. Hospital-acquired Infections (Hais) 9.5. Human Papillomavirus (Hpv) 9.6 Tuberculosis (Tb) 9.7. Influenza 9.8. Others 10. Global Infectious Disease Testing Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Hospital/Clinical Laboratories 10.2. Reference Laboratories 10.3. Physician Offices 10.4. Academic/Research Institutes 10.5. Others 11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2020-2027 12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2020-2027 13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2020-2027 14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Saudi Arabia 15.2.2. UAE 15.2.3. South Africa 15.2.4. Egypt 15.3. Market Size (USD Million) Forecast for MEA 2020-2027 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 16.1. Abbott Laboratories 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Becton 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Dickinson And Company 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Biomérieux Sa 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5 Bio-rad Laboratories 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6 Danaher Corporation 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Diasorin 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Luminex 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Meridian Bioscience 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10. Quidel 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11. Roche Diagnostics 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12. Siemens Healthineers 16.12.1. Company Overview 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13. Thermo Fisher Scientific 16.13.1. Company Overview 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 17. Impact of COVID-19 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the healthcare regulations initiated by administrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME Key Takeaway Points for Client
1. Market Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Scope
1.3.1. Years Considered for the Study
1.3.2. Market Covered
1.4. Currency
1.5. Limitations
1.6. Stakeholders
2. Research Methodology
2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data
2.1.2.1. Key Data from Primary Sources
2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation
2.4. Assumptions for the Study
3. Executive Summary
3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Global Infectious Disease Testing Market Variables, Trends & Scope
4.1. Market Lineage Outlook
4.2. Penetration and Growth Prospect Mapping
4.3. Industry Value Chain Analysis
4.4. Cost Analysis Breakdown
4.5. Technology Overview
4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Global Infectious Disease Testing Market Overview
5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Infectious Disease Testing Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Infectious Disease Testing Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Global Infectious Disease Testing Market, By Product & Service Historical Analysis and Forecast 2020-2027 (USD Million)
7.1. Assays, Kits, & Reagents
7.2. Instruments
7.3. Services & Software
8. Global Infectious Disease Testing Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million)
8.1. Immunodiagnostics
8.2. Clinical Microbiology
8.3. Polymerase Chain Reaction (Pcr)
8.4. Isothermal Nucleic Acid Amplification Technology (Inaat)
8.5. Dna Sequencing & Next-generation Sequencing (Ngs)
8.6. Dna Microarray
8.7. Other Technologies
9. Global Infectious Disease Testing Market, By Disease Type Historical Analysis and Forecast 2020-2027 (USD Million)
9.1. Hepatitis
9.2. Human Immunodeficiency Virus (Hiv)
9.3. Chlamydia Trachomatis Genital Infection And Gonorrhea (Ct/Ng)
9.4. Hospital-acquired Infections (Hais)
9.5. Human Papillomavirus (Hpv)
9.6 Tuberculosis (Tb)
9.7. Influenza
9.8. Others
10. Global Infectious Disease Testing Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
10.1. Hospital/Clinical Laboratories
10.2. Reference Laboratories
10.3. Physician Offices
10.4. Academic/Research Institutes
10.5. Others
11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
11.1. Introduction
11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
11.2.1. U.S.A
11.2.2. Canada
11.2.3. Mexico
11.3. Market Size (USD Million) Forecast for North America 2020-2027
12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
12.1. Introduction
12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
12.2.1. Brazil
12.2.2. Venezuela
12.2.3. Argentina
12.2.4. Rest of Latin America
12.3. Market Size (USD Million) Forecast for Latin America 2020-2027
13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
13.1. Introduction
13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
13.2.1. Germany
13.2.2. U.K
13.2.3. France
13.2.4. Italy
13.2.5. Spain
13.2.6. Russia
13.2.7. Poland
13.2.8. Rest of Europe
13.3. Market Size (USD Million) Forecast for Europe 2020-2027
14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
14.1. Introduction
14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
14.2.1. Japan
14.2.2. China
14.2.3. India
14.2.4. Australia and New Zealand
14.2.5. ASEAN
14.2.6. Rest of Asia Pacific
14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
15.1. Introduction
15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
15.2.1. Saudi Arabia
15.2.2. UAE
15.2.3. South Africa
15.2.4. Egypt
15.3. Market Size (USD Million) Forecast for MEA 2020-2027
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
16.1. Abbott Laboratories
16.1.1. Company Overview
16.1.2. Product Portfolio
16.1.3. SWOT Analysis
16.1.4. Financial Overview
16.1.5. Strategic Overview
16.2. Becton
16.2.1. Company Overview
16.2.2. Product Portfolio
16.2.3. SWOT Analysis
16.2.4. Financial Overview
16.2.5. Strategic Overview
16.3. Dickinson And Company
16.3.1. Company Overview
16.3.2. Product Portfolio
16.3.3. SWOT Analysis
16.3.4. Financial Overview
16.3.5. Strategic Overview
16.4. Biomérieux Sa
16.4.1. Company Overview
16.4.2. Product Portfolio
16.4.3. SWOT Analysis
16.4.4. Financial Overview
16.4.5. Strategic Overview
16.5 Bio-rad Laboratories
16.5.1. Company Overview
16.5.2. Product Portfolio
16.5.3. SWOT Analysis
16.5.4. Financial Overview
16.5.5. Strategic Overview
16.6 Danaher Corporation
16.6.1. Company Overview
16.6.2. Product Portfolio
16.6.3. SWOT Analysis
16.6.4. Financial Overview
16.6.5. Strategic Overview
16.7. Diasorin
16.7.1. Company Overview
16.7.2. Product Portfolio
16.7.3. SWOT Analysis
16.7.4. Financial Overview
16.7.5. Strategic Overview
16.8. Luminex
16.8.1. Company Overview
16.8.2. Product Portfolio
16.8.3. SWOT Analysis
16.8.4. Financial Overview
16.8.5. Strategic Overview
16.9. Meridian Bioscience
16.9.1. Company Overview
16.9.2. Product Portfolio
16.9.3. SWOT Analysis
16.9.4. Financial Overview
16.9.5. Strategic Overview
16.10. Quidel
16.10.1. Company Overview
16.10.2. Product Portfolio
16.10.3. SWOT Analysis
16.10.4. Financial Overview
16.10.5. Strategic Overview
16.11. Roche Diagnostics
16.11.1. Company Overview
16.11.2. Product Portfolio
16.11.3. SWOT Analysis
16.11.4. Financial Overview
16.11.5. Strategic Overview
16.12. Siemens Healthineers
16.12.1. Company Overview
16.12.2. Product Portfolio
16.12.3. SWOT Analysis
16.12.4. Financial Overview
16.12.5. Strategic Overview
16.13. Thermo Fisher Scientific
16.13.1. Company Overview
16.13.2. Product Portfolio
16.13.3. SWOT Analysis
16.13.4. Financial Overview
16.13.5. Strategic Overview
17. Impact of COVID-19
17.1. Positive influence on the healthcare industry
17.2. The financial disruption of the manufacturing sector
17.3. Impact of COVID-19 on emerging companies
17.4. Significant mandates in the healthcare regulations initiated by administrations
17.5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics